Mineralys Therapeutics’ $192 Million Initial Public Offering

Pietro Martinoia North America Legal Chronicle
Tagged:

Latham & Watkins advised Mineralys Therapeutics, and Shearman & Sterling advised the underwriters.Mineralys Therapeutics, Inc. (Nasdaq: MLYS) announced the pricing of its upsized initial public offering…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Pietro Martinoia

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here